1. What data in particular will be shared?
   Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).
   


2. What additional supporting information will be shared?
   Response -  Study Protocol
   Response -  Statistical Analysis Plan
   Response - Informed Consent Form
   Response - Clinical Study Report
   Response -  Analytic Code
   
   
3. Who will be able to view these files?
   Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.
   


4. For what types of analyses will this data be available?
   Response - For individual participant data meta-analysis.
   


5. By what mechanism will data be made available?
   Response - Proposals should be directed to [liyanr@gwu.ac.lk].
   


6. For how long will this data be available start date provided 10-09-2024 and end date provided 01-09-2029?
   Response - Beginning 3 months and ending 5 years following article publication.
   


7. Any URL or additional information regarding plan/policy for sharing IPD? 
   Additional Information - NIL

The term Chittodvega correlated with the symptomatological explanation of Generalised Anxiety Disorder (GAD). The global prevalence of anxiety disorders in 2019 was 4.05%. Medications that widely use in anxiety have been found with considerable amount of adverse drug events. Both psychotherapy and pharmacotherapy have been shown to be more effective in previous research studies. Therefore, the study is planned with a combination of Sarvanga abhyanga with Ksheerabala oil, Sarvanga Parisheka with Dashamula Kwatha, Thakradhara, Ashwagandha and Yashtimadhu churna with milk, Shiva panchakshari mantra japa listening, Buddhist meditation and Psychotherapy for a period of five days. All the interventions planned in the study have already depicted positive impact separately in the management of Chittodvega w.s.r to GAD and current study expects to observe the combined effect of the selected protocol. Main objective of this study is to evaluate the effectiveness of integrated treatment modality in Chittodvega W.S.R. to Generalised Anxiety Disorder. The study will be an open labeled single arm clinical trial in the inpatient department at Shri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital, Hassan. Data will be collected using specially prepared case report forms, irrespective of caste, sex and religion. Sample size is 35. Participants will be diagnosed on the basis of 6B00 Generalised Anxiety Disorder ICD-11.  Participants who are willing to give informed consent and comply with study procedures irrespective of gender and socio-economic status and between 18-60 years of age will be included and pregnant and lactating females, individuals with comorbid psychiatric disorders and those who are unable to undergo with the selected treatment protocol will be excluded. Hamilton Anxiety Rating Scale and Galvanic Skin Response will be used for the assessment at 0^th day before treatment, 03^rd day at treatment and 06^th day after the treatment. The data will be analyzed using an appropriate statistical software.